CompuGroup Medical
Synchronizing Healthcare

We promote dialog in the healthcare sector and ensure that costs are saved in a meaningful way. Everyone should benefit from medical progress with the help of IT.

Investor Relations

Investment highlights

Strong market positions  

Technology leadership

Continuous investments in user experience and interoperability

Recurring revenue share > 60%

Sustainable revenue & EBITDA growth with high margins

Strong cashflow profile driving TSR

Excellent track record in value enhancing M&A

€1 bnRevenues expected in 2021
+5%organic growth
20-23%Adjusted EBITDA margin

Digitization in healthcare accelerates growth

CompuGroup Medical expects continued strong organic growth in 2022 and first step towards higher margins

CGM confirms guidance after strong third quarter

CompuGroup Medical announces medium-term targets for EBITDA-margin for the first time and confirms 2021 guidance